KR102266295B1 - 간섭 펩티드 및 미생물 검출 방법 - Google Patents

간섭 펩티드 및 미생물 검출 방법 Download PDF

Info

Publication number
KR102266295B1
KR102266295B1 KR1020147028445A KR20147028445A KR102266295B1 KR 102266295 B1 KR102266295 B1 KR 102266295B1 KR 1020147028445 A KR1020147028445 A KR 1020147028445A KR 20147028445 A KR20147028445 A KR 20147028445A KR 102266295 B1 KR102266295 B1 KR 102266295B1
Authority
KR
South Korea
Prior art keywords
sequence
peptide
microorganism
amino acids
interfering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147028445A
Other languages
English (en)
Korean (ko)
Other versions
KR20140132410A (ko
Inventor
플로랭스 벳스워스
까뜨린느 뽀티용
베라트리스 세이그네르
Original Assignee
비오메리으
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비오메리으 filed Critical 비오메리으
Publication of KR20140132410A publication Critical patent/KR20140132410A/ko
Application granted granted Critical
Publication of KR102266295B1 publication Critical patent/KR102266295B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020147028445A 2012-03-09 2013-03-11 간섭 펩티드 및 미생물 검출 방법 Active KR102266295B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1252142 2012-03-09
FR1252142A FR2987836A1 (fr) 2012-03-09 2012-03-09 Peptides d'interference et procede de detection de microorganismes
PCT/FR2013/050504 WO2013132198A1 (fr) 2012-03-09 2013-03-11 Peptides d'interférence et procédé de détection de microorganismes

Publications (2)

Publication Number Publication Date
KR20140132410A KR20140132410A (ko) 2014-11-17
KR102266295B1 true KR102266295B1 (ko) 2021-06-18

Family

ID=48083475

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147028445A Active KR102266295B1 (ko) 2012-03-09 2013-03-11 간섭 펩티드 및 미생물 검출 방법

Country Status (9)

Country Link
US (1) US9606120B2 (https=)
EP (1) EP2825883B1 (https=)
JP (1) JP6357425B2 (https=)
KR (1) KR102266295B1 (https=)
CN (2) CN111995666A (https=)
BR (1) BR112014022145A2 (https=)
ES (1) ES2674672T3 (https=)
FR (1) FR2987836A1 (https=)
WO (1) WO2013132198A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160051669A1 (en) * 2014-08-21 2016-02-25 Georgia Regents University Research Institute, Inc. Compositions and methods for selectively modulating tregs
MX2020002611A (es) 2017-09-07 2020-07-13 Univ Res Inst Inc Augusta Activador especifico de akt3 y usos del mismo.
US20200077906A1 (en) 2018-09-07 2020-03-12 Augusta University Research Institute, Inc. Method and System for Monitoring Brain Function and Intracranial Pressure

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003192697A (ja) * 1990-11-03 2003-07-09 Dade Behring Marburg Gmbh Ｈｃｖ−特異的ペプチドおよびそれらの使用
WO2008027942A2 (en) 2006-09-01 2008-03-06 Abbott Laboratories Combination hepatitis c virus antigen and antibody detection method

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931385A (en) 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
US4818686A (en) 1986-09-15 1989-04-04 Coulter Corporation Chemical blocking agent against non-specific binding or staining of an antibody specific for terminal deoxynucleotidyl transferase in biological specimens during immunoassay
US5077198A (en) 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
DK0644202T3 (da) * 1990-12-14 1997-09-15 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
JPH07500190A (ja) * 1992-03-26 1995-01-05 マントティフィオーレ、メディカル、センター 免疫試験中の誤反応を防止する技術
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
FR2710075B1 (fr) 1993-09-15 1995-10-27 Bio Merieux Réactif et procédé pour la détection d'une séquence nucléotidique avec amplification de signal.
WO1997043310A1 (en) * 1996-05-10 1997-11-20 Schering Corporation Synthetic inhibitors of hepatitis c virus ns3 protease
DE19720914A1 (de) * 1997-05-16 1998-11-19 Boehringer Mannheim Gmbh Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten
EP0922958B1 (de) * 1997-12-11 2002-10-02 Roche Diagnostics GmbH Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
US7608273B2 (en) * 1998-08-12 2009-10-27 University Of Western Ontario Recombinant lentivirus encoding modified GP 120 signal sequences
CU23235A1 (es) * 2001-02-28 2007-09-26 Ct Ingenieria Genetica Biotech POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA
CN102131522A (zh) * 2007-01-12 2011-07-20 西安大略省大学 Hiv联合疫苗与初免加强方法
WO2010112733A1 (fr) * 2009-03-30 2010-10-07 bioMérieux Support solide de détection du vhc
EA022788B1 (ru) * 2009-07-03 2016-03-31 Бионор Иммуно Ас Новые терапевтические и диагностические средства
KR101989978B1 (ko) * 2011-12-23 2019-06-17 더 유니버시티 오브 웨스트 온타리오 프라임 부스트 백신용 수포성 구내염 바이러스

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003192697A (ja) * 1990-11-03 2003-07-09 Dade Behring Marburg Gmbh Ｈｃｖ−特異的ペプチドおよびそれらの使用
WO2008027942A2 (en) 2006-09-01 2008-03-06 Abbott Laboratories Combination hepatitis c virus antigen and antibody detection method

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
UniProtKB: locus EFP_PSEE4, accession Q1ID35 (sequence updated: Jun 13, 2006) 1부.*
UniProtKB: locus EMP_STAAW, accession Q8NXI8 (sequence updated: Oct 1, 2002) 1부.*
UniProtKB: locus METQ_BACSU, accession O32167 (sequence updated: Jan 1, 1998) 1부.*
UniProtKB: locus RSMH_STRZT, accession C1CPL0 (sequence updated: May 26, 2009) 1부.*
UniProtKB: locus TRMD_MYCPN, accession P75132 (sequence updated: Dec 6, 2002) 1부.*

Also Published As

Publication number Publication date
JP6357425B2 (ja) 2018-07-11
US20150024380A1 (en) 2015-01-22
JP2015510876A (ja) 2015-04-13
CN111995666A (zh) 2020-11-27
KR20140132410A (ko) 2014-11-17
US9606120B2 (en) 2017-03-28
CN104285149A (zh) 2015-01-14
WO2013132198A1 (fr) 2013-09-12
EP2825883A1 (fr) 2015-01-21
BR112014022145A2 (pt) 2017-07-11
EP2825883B1 (fr) 2018-05-09
FR2987836A1 (fr) 2013-09-13
ES2674672T3 (es) 2018-07-03

Similar Documents

Publication Publication Date Title
US4748110A (en) Immunoassay for HTLV-III antigens
US5462852A (en) HIV Nucleocapsid protein capture assay and method of use
EP0345462B1 (en) Immunoassay for HIV-1 antigens using F(AB')2 fragments as probe
CN111856027B (zh) 适用于无明显症状者排查的新冠病毒抗体检测试剂盒
WO1993021346A1 (en) Assay for detection of hiv antigen and hiv antibody
Zhao et al. Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteins
KR102266295B1 (ko) 간섭 펩티드 및 미생물 검출 방법
EP4298113A1 (en) Peptides and their use in diagnosis of sars-cov-2 infection
US20150168406A1 (en) Method for diagnosing and differentiating hiv-2 infections
EP0386713A2 (en) Immunoassay for antibodies to HIV
JP7523129B2 (ja) ヘリコバクター・ピロリ菌株の同定方法、および同定用キット
CN101523216B (zh) 人类免疫缺陷病毒系列蛋白抗体测定方法
Varečková et al. Comparison of 44/107L one-step immunocapture enzyme-immunoassay and time-resolved fluoroimmunoassay for influenza A diagnosis
Zhou et al. Characterization and application of a series of monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein
CN113030468A (zh) 降低误检可能性的SARS-CoV-2抗体检测试剂盒
US11099187B2 (en) Process for determining a humoral response in an immunodepressed patient
CN120004992B (zh) 一种检测布鲁氏菌感染产生的抗体的抗原表位多肽及其应用
RU2283497C1 (ru) ИММУНОФЕРМЕНТНАЯ ТЕСТ-СИСТЕМА ДЛЯ ИДЕНТИФИКАЦИИ СПЕКТРА АНТИТЕЛ К ВИЧ 1 И 2 ВЫЯВЛЕНИЯ АНТИГЕНА ВИЧ 1 (p24) "ДС-ИФА-АНТИ-ВИЧ 1 И 2, ВИЧ 1 ГРУППЫ О-СПЕКТР+АГ p24 ВИЧ 1"
CN109991429B (zh) 一种禽流感h5、h7和np蛋白抗体检测试剂盒及其应用方法
WO2023242155A1 (en) Compositions and methods for the diagnosis of hiv infection
JPH05188057A (ja) Ｈｉｖ−１抗体の免疫酵素的検出法
CN115201465A (zh) 基于多肽芯片的抗体特异性结合的多肽的筛选方法及其筛选的多肽的应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141008

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180209

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191023

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20200629

Patent event code: PE09021S02D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201222

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210407

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210611

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210614

End annual number: 3

Start annual number: 1

PG1601 Publication of registration